ClinicalTrials.gg
RecruitingNCT07489235Updated Sep 8, 2026

Effects of Different Wrist Positions in Dorsal Blocking Orthoses After Flexor Tendon Repair

An interventional study of 3D-Printed Dorsal Blocking Orthosis (wrist 30 degree extension) and 3D-Printed Dorsal Blocking Orthosis (wrist neutral) in Flexor Tendon Injury and Tendon Injury - Hand, sponsored by Sedanur Güngör. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2026-09-08.

Sponsored by Sedanur Güngör · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Apr 2026; still recruiting 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
16 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 18 studies in Hand Injuries with a site in Turkey — 9 open to participants now, 9 under way, none of them phase 3. Hand Injuries · Turkey.

Planned enrollment
4th of 10
64 · median 60
Started
2026
with 5 others
No phase
10 of 18
3 open now
Registered
16th of 18
by date

Among the 18 studies in Hand Injuries with a site in Turkey, this one is the 4th largest by planned enrollment of the 10 interventional ones that give a count, is one of 6 that started in 2026, is one of 10 with no phase, and was the 16th registered.

Hand Injuries

122 studies on the registry are indexed under Hand Injuries; 35 are open to participants now.

Browse Hand Injuries studies →

Open to participants now

9 of the 18 studies in Hand Injuries with a site in Turkey are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 26 Hand Injuries studies recruiting now, 14 (54%) set no upper age limit and 10 (38%) stop at 75 or younger; 4 take children under 18; 5 take healthy volunteers.

This study: 16 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Hand Injuries with a site in Turkey, or all of them as a file.
02

Study summary

This randomized controlled study aims to compare the effects of three different wrist positions (30° extension, neutral, and 30° flexion) used in dorsal blocking orthoses during early active mobilization after zone I-II flexor tendon repair. A total of 54 patients will be randomly assigned into three groups. All participants will receive the same rehabilitation protocol. Clinical and functional outcomes including total active motion, pain, complications, functional status, and orthosis satisfaction will be evaluated at 6, 8, and 12 weeks by a blinded assessor.

03

Conditions studied

  • Flexor Tendon Injury
  • Tendon Injury - Hand

Keywords

  • flexor tendon
  • orthosis
  • splint
  • 3D printing
  • therapy
  • rehabilitation
  • immobilization
04

Who can participate

Ages eligible
16 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals aged 16 years and older
  • Patients who underwent zone I or II flexor tendon repair using at least a four--strand suture technique
  • Referral to physiotherapy within the first 10 days after surgery
  • Eligibility for a controlled early active mobilization protocol
  • Ability to understand and complete Turkish assessment questionnaires
  • Adequate cognitive function ( score >21)
  • Voluntary participation with written

Exclusion criteria

Exclusion Criteria:

  • Thumb tendon repairs
  • Multiple or complex injuries (e.g., concomitant peripheral nerve injury, fractures requiring immobilization, joint dislocation, extensor tendon injury)
  • Active infection
  • Severe edema preventing orthosis use
  • Dermatological conditions or allergies preventing orthosis application
  • Systemic diseases that may affect rehabilitation (e.g., diabetes mellitus, -peripheral neuropathy, stroke, advanced rheumatoid arthritis)
  • Pre-existing wrist pain or deformity prior to injury
  • Inability to attend follow-up assessments
  • Non-compliance with the home exercise program
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Wrist Extension Group

    Participants will use a 3D-printed dorsal blocking orthosis with the wrist positioned at 30° extension and follow a controlled early active mobilization protocol.

    Device: 3D-Printed Dorsal Blocking Orthosis (wrist 30 degree extension)

  • Experimental
    Neutral Wrist Group

    Participants will use a 3D-printed dorsal blocking orthosis with the wrist in neutral position and follow the same rehabilitation protocol.

    Device: 3D-Printed Dorsal Blocking Orthosis (wrist neutral)

  • Experimental
    Wrist Flexion Group

    Participants will use a 3D-printed dorsal blocking orthosis with the wrist positioned at 30° flexion and follow the same rehabilitation protocol.

    Device: 3D-Printed Dorsal Blocking Orthosis (wrist 30 degree flexion)

Interventions

  • Device3D-Printed Dorsal Blocking Orthosis (wrist 30 degree extension)

    Participants will use a 3D-printed dorsal blocking orthosis with the wrist positioned at 30° extension and follow a controlled early active mobilization protocol.

    Also known as: Early Active Mobilization Protocol

  • Device3D-Printed Dorsal Blocking Orthosis (wrist neutral)

    Participants will use a 3D-printed dorsal blocking orthosis with the wrist in neutral position and follow the same rehabilitation protocol.

    Also known as: Early Active Mobilization Protocol

  • Device3D-Printed Dorsal Blocking Orthosis (wrist 30 degree flexion)

    Participants will use a 3D-printed dorsal blocking orthosis with the wrist positioned at 30° flexion and follow the same rehabilitation protocol.

    Also known as: Early Active Mobilization Protocol

06

What researchers measure

Primary outcomes

  1. Total Active Motion (TAM)

    Total active motion will be calculated by summing the active flexion angles of the metacarpophalangeal, proximal interphalangeal, and distal interphalangeal joints and subtracting any extension deficits. Measurements will be performed using a finger goniometer and evaluated according to the Buck-Gramcko classification.

    Time frame: 12 week

Secondary outcomes

  1. Pain Intensity

    Pain intensity will be assessed using a Numeric Rating Scale (NRS) ranging from 0 (no pain) to 10 (worst possible pain).

    Time frame: 6, 8, and 12 weeks

  2. Hand Function

    Hand function will be evaluated using the Jebsen-Taylor Hand Function Test, which measures the time required to complete standardized hand tasks.

    Time frame: 6, 8 and 12 weeks

  3. Upper Extremity Function

    Upper extremity functional status will be assessed using the Quick Disabilities of the Arm, Shoulder, and Hand (QuickDASH) questionnaire. Lower scores indicate better function.

    Time frame: 6, 8, and 12 weeks

  4. Grip Strength

    Grip strength will be measured using a hydraulic hand dynamometer and recorded in kilograms.

    Time frame: 6, 8, and 12 weeks

  5. Pinch Strength

    Pinch strength will be measured using a pinch meter and recorded in kilograms.

    Time frame: 6, 8, and 12 weeks

  6. Orthosis Satisfaction

    Patient satisfaction with the orthosis will be assessed using the Orthotics and Prosthetics Users' Survey (OPUS).

    Time frame: 6 weeks

  7. Complications

    Postoperative complications including tendon rupture, adhesions, edema, and skin irritation will be recorded during the follow-up period.

    Time frame: up to 12 weeks

  8. Return to Daily Activities

    Time to return to daily activities and work will be recorded in weeks.

    Time frame: Up to 12 weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2026 (actual). Primary completion is estimated for Mar 2028, 22 months after the start.

Of 59 non-industry interventional studies with no phase under Hand Injuries, half reached primary completion within 14 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 26. This study's planned 22 months is above that.

Counting every sponsor, half of 59 studies reached it within 14 months; a quarter within 8 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 19, 2026
First posted
Mar 24, 2026
StartActual
Apr 20, 2026
Primary completionEst.
Mar 6, 2028
CompletionEst.
Aug 6, 2028
Last update
Sep 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07489235
Lead sponsor
Sedanur Güngör
Collaborators
Gazi University
Responsible party
Sedanur Güngör (Principal Investigator, Gazi University) — Sponsor-investigator
First posted
Mar 24, 2026
Start date
Apr 20, 2026
Primary completion
Mar 6, 2028 (estimated)
Completion
Aug 6, 2028 (estimated)
Last update
Sep 8, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion